Skip to Main Content

BioPathways + Women In Bio: The Impact of COVID on Abbott’s Innovation

March 9, 2021 — 5:00 pm - 6:00 pm

In this online session, hear from Andrea Wainer, Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. Andrea leads four innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; another the world’s leading provider of rapid point-of-care diagnostics; a third providing a leading hand-held point of care device; and finally, a world-class informatics solution provider. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.

Register for the Zoom meeting here